Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
8 Patents
#44 in Watertown, MA
#2,098 in Massachusetts
#35,924 in US
Tarveda Therapeutics, Inc.
Forward Citations = 10
19 inventors:
Watertown, MA, United States of America
Tarveda Therapeutics, Inc.
% Expired Patents = 75.0
CIPO Patents = 1
Forward Citations = 10
Loading Chart...
Loading Chart...
19 inventors (with patents filed for the assignee):
Rajesh R Shinde (7 out of 14 patents)
Mark T Bilodeau (7 out of 58 patents)
Richard Wooster (6 out of 11 patents)
4. Rossitza Gueorguieva Alargova (5 out of 24 patents)
5. Beata Sweryda-Krawiec (5 out of 6 patents)
6. Sudhakar Kadiyala (5 out of 21 patents)
7. Brian H White (4 out of 12 patents)
8. Patrick Rosaire Bazinet (4 out of 5 patents)
9. Patrick Lim Soo (4 out of 8 patents)
10. Craig Antony Dunbar (4 out of 9 patents)
11. Kerry Whalen (2 out of 7 patents)
12. Leila Alland (2 out of 2 patents)
13. Benoît Moreau (1 out of 15 patents)
14. Mary Simcox (1 out of 1 patent)
15. Christopher Sears (1 out of 1 patent)
8 patents:
Company Overview
Tarveda Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative cancer therapies using its proprietary Pentarins platform. These targeted cancer drugs are designed to deliver potent anticancer agents directly to tumor cells, minimizing systemic side effects and maximizing therapeutic potential.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tarveda Therapeutics, Inc.. Retrieved from https://idiyas.com/company/tarveda-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]